Blue Mars 2022
in Cancer prevention
Posted on 03/04/2022
The prognosis is linked to the stage at which the cancer develops: the smaller and more limited the cancer, the simpler the treatment and the greater the chances of a cure.
If detected early, colorectal cancer can be cured in 9 out of 10 cases.
WHO IS CONCERNED BY COLORECTAL CANCER SCREENING?
The organised colorectal cancer screening programme is open to anyone aged between 50 and 74. In the southern Provence-Alpes-Côte d'Azur region, almost 1,591,833 people are involved. The percentage of cancers detected in the eligible population is 0.34%. Since 2008, this represents around 6,000 cancers detected in the southern PACA region.
The percentage of precancerous lesions in the eligible population is, on average, 1% (varying by department). Since 2008, this represents around 12,500 people in the southern PACA region for whom screening has prevented cancer.
You are not eligible for screening if :
- A personal history of colorectal cancer or adenomas ;
- A family history of colorectal cancer (one first-degree relative affected by this cancer before the age of 65 or two first-degree relatives of any age);
- Chronic inflammatory disease (haemorrhagic rectocolitis or Crohn's disease);
- Familial adenomatous polyposis, hereditary non-polyposis colorectal cancer (HNPCC or Lynch syndrome).
In all cases, it is up to the GP to assess the patient's level of risk, based on their personal and/or family history. The doctor may suggest that the patient undergo a screening test or undergo appropriate monitoring.
WHAT ARE THE TESTS?
Polyps and cancers may bleed intermittently. The screening test can identify this occult blood (i.e. not visible to the naked eye) in the stools and prove the presence of a polyp.
Since April 2015, the national organised screening programme has been offering a new test: the immunological test.
The new OC Sensor screening test - known as the immunological test
Violaine PALA
Nurse coordinator
AXIUM Clinic